BioLife Solutions, Inc. (BLFS)
USD 24.98
(-7.03%)
USD 24.98
(-7.03%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -45.23 Million USD | -53.28% |
| 2022 | -23.19 Million USD | -23.06% |
| 2021 | -17.78 Million USD | -705.88% |
| 2020 | 1.07 Million USD | -392.91% |
| 2019 | -884 Thousand USD | -72.26% |
| 2018 | -24.66 Million USD | 446.78% |
| 2017 | -1.78 Million USD | 48.86% |
| 2016 | -7.35 Million USD | 58.84% |
| 2015 | -4.67 Million USD | -60.0% |
| 2014 | -2.85 Million USD | -3205.28% |
| 2013 | -38.28 Thousand USD | 87.47% |
| 2012 | -772.59 Thousand USD | 31.97% |
| 2011 | -1.11 Million USD | 15.77% |
| 2010 | -1.32 Million USD | 39.76% |
| 2009 | -2.18 Million USD | 8.68% |
| 2008 | -2.41 Million USD | 1.91% |
| 2007 | -2.67 Million USD | -32.47% |
| 2006 | -1.02 Million USD | -227.26% |
| 2005 | -561.44 Thousand USD | -13.46% |
| 2004 | -492.22 Thousand USD | 68.17% |
| 2003 | -1.13 Million USD | -246.48% |
| 2002 | -451.23 Thousand USD | 89.0% |
| 2001 | -266.65 Thousand USD | -57.49% |
| 2000 | -2.6 Million USD | -213.58% |
| 1999 | -861.17 Thousand USD | 7.86% |
| 1998 | -901.23 Thousand USD | 27.09% |
| 1997 | -1.23 Million USD | 0.0% |
| 1996 | - USD | 100.0% |
| 1995 | -3.01 Million USD | 42.26% |
| 1994 | -1.38 Million USD | 65.22% |
| 1993 | -2.4 Million USD | -38.0% |
| 1992 | -6.7 Million USD | -85.19% |
| 1991 | -4.7 Million USD | -88.0% |
| 1990 | -2.5 Million USD | -66.67% |
| 1989 | -1.5 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -7.61 Million USD | 27.82% |
| 2024 Q2 | -385 Thousand USD | 42.47% |
| 2023 Q1 | -11.03 Million USD | -32.56% |
| 2023 FY | - USD | -53.28% |
| 2023 Q2 | -14.35 Million USD | -30.15% |
| 2023 Q4 | -11.18 Million USD | 1.51% |
| 2023 Q3 | -11.35 Million USD | 20.89% |
| 2022 FY | - USD | -23.06% |
| 2022 Q1 | -9.76 Million USD | 16.55% |
| 2022 Q2 | -4.27 Million USD | 56.23% |
| 2022 Q3 | -3.09 Million USD | 27.52% |
| 2022 Q4 | -8.32 Million USD | -168.62% |
| 2021 FY | - USD | -705.88% |
| 2021 Q3 | -14.67 Million USD | -1222.8% |
| 2021 Q2 | 1.3 Million USD | 20.24% |
| 2021 Q4 | -11.7 Million USD | 20.27% |
| 2021 Q1 | 1.08 Million USD | -69.49% |
| 2020 Q1 | -20.53 Million USD | -2251.89% |
| 2020 Q3 | -291 Thousand USD | -102.04% |
| 2020 Q4 | 3.56 Million USD | 1324.4% |
| 2020 FY | - USD | -392.91% |
| 2020 Q2 | 14.29 Million USD | 169.61% |
| 2019 Q4 | -873 Thousand USD | -2397.37% |
| 2019 Q1 | 736 Thousand USD | -29.43% |
| 2019 Q2 | 1.09 Million USD | 48.51% |
| 2019 FY | - USD | -72.26% |
| 2019 Q3 | 38 Thousand USD | -96.52% |
| 2018 Q1 | 82.2 Thousand USD | 137.71% |
| 2018 FY | - USD | 446.78% |
| 2018 Q4 | 1.04 Million USD | -20.73% |
| 2018 Q3 | 1.31 Million USD | 7.51% |
| 2018 Q2 | 1.22 Million USD | 1388.82% |
| 2017 Q1 | -697.4 Thousand USD | -132.3% |
| 2017 Q2 | -576.92 Thousand USD | 17.28% |
| 2017 FY | - USD | 48.86% |
| 2017 Q4 | -218 Thousand USD | 6.84% |
| 2017 Q3 | -233.99 Thousand USD | 59.44% |
| 2016 Q3 | -1.13 Million USD | 29.66% |
| 2016 Q2 | -1.61 Million USD | -8.5% |
| 2016 Q1 | -1.49 Million USD | -6.28% |
| 2016 FY | - USD | 58.84% |
| 2016 Q4 | 2.15 Million USD | 289.56% |
| 2015 Q3 | -1.2 Million USD | -13.1% |
| 2015 Q2 | -1.06 Million USD | 0.31% |
| 2015 Q4 | -1.4 Million USD | -16.55% |
| 2015 FY | - USD | -60.0% |
| 2015 Q1 | -1.06 Million USD | -6.41% |
| 2014 FY | - USD | -3205.28% |
| 2014 Q4 | -1 Million USD | -24.99% |
| 2014 Q3 | -803.47 Thousand USD | 2.39% |
| 2014 Q2 | -823.13 Thousand USD | -157.59% |
| 2014 Q1 | -319.55 Thousand USD | -35.87% |
| 2013 Q2 | -37.38 Thousand USD | -120.96% |
| 2013 Q3 | -59.36 Thousand USD | -58.8% |
| 2013 Q4 | -235.19 Thousand USD | -296.16% |
| 2013 FY | - USD | 87.47% |
| 2013 Q1 | 178.37 Thousand USD | 176.79% |
| 2012 Q4 | -232.29 Thousand USD | -136.87% |
| 2012 Q3 | -98.06 Thousand USD | 64.17% |
| 2012 Q1 | -152.8 Thousand USD | 17.06% |
| 2012 Q2 | -273.7 Thousand USD | -79.12% |
| 2012 FY | - USD | 31.97% |
| 2011 Q4 | -184.24 Thousand USD | 29.19% |
| 2011 Q2 | -236.68 Thousand USD | 45.13% |
| 2011 Q1 | -431.38 Thousand USD | -47.12% |
| 2011 Q3 | -260.2 Thousand USD | -9.94% |
| 2011 FY | - USD | 15.77% |
| 2010 FY | - USD | 39.76% |
| 2010 Q4 | -293.21 Thousand USD | -10.93% |
| 2010 Q3 | -264.31 Thousand USD | 28.25% |
| 2010 Q2 | -368.36 Thousand USD | 4.94% |
| 2010 Q1 | -387.51 Thousand USD | -87.93% |
| 2009 Q1 | -723.82 Thousand USD | -7.09% |
| 2009 Q3 | -404.55 Thousand USD | 52.96% |
| 2009 Q2 | -860.02 Thousand USD | -18.82% |
| 2009 Q4 | -206.2 Thousand USD | 49.03% |
| 2009 FY | - USD | 8.68% |
| 2008 FY | - USD | 1.91% |
| 2008 Q2 | -598.45 Thousand USD | -17.34% |
| 2008 Q4 | -675.9 Thousand USD | -16.26% |
| 2008 Q1 | -510 Thousand USD | -15.92% |
| 2008 Q3 | -581.37 Thousand USD | 2.86% |
| 2007 Q3 | -710.26 Thousand USD | 1.33% |
| 2007 Q1 | -577.57 Thousand USD | 31.22% |
| 2007 Q2 | -719.81 Thousand USD | -24.63% |
| 2007 Q4 | -439.95 Thousand USD | 38.06% |
| 2007 FY | - USD | -32.47% |
| 2006 Q3 | -382.48 Thousand USD | 12.07% |
| 2006 Q4 | -839.74 Thousand USD | -119.55% |
| 2006 FY | - USD | -227.26% |
| 2006 Q1 | -197.63 Thousand USD | -26.53% |
| 2006 Q2 | -435 Thousand USD | -120.1% |
| 2005 Q1 | -152.36 Thousand USD | -964.24% |
| 2005 Q2 | -173.43 Thousand USD | -13.83% |
| 2005 Q3 | -140.94 Thousand USD | 18.73% |
| 2005 Q4 | -156.2 Thousand USD | -10.82% |
| 2005 FY | - USD | -13.46% |
| 2004 Q2 | -221.7 Thousand USD | -32.1% |
| 2004 FY | - USD | 68.17% |
| 2004 Q4 | 17.63 Thousand USD | 112.86% |
| 2004 Q3 | -137.08 Thousand USD | 38.17% |
| 2004 Q1 | -167.82 Thousand USD | 44.19% |
| 2003 Q4 | -86.02 Thousand USD | 40.66% |
| 2003 FY | - USD | -246.48% |
| 2003 Q1 | 54.37 Thousand USD | 125.75% |
| 2003 Q2 | -481.2 Thousand USD | -1040.24% |
| 2003 Q3 | -506.73 Thousand USD | -5.3% |
| 2002 FY | - USD | 89.0% |
| 2002 Q1 | 39.09 Thousand USD | 54.59% |
| 2002 Q3 | -106.6 Thousand USD | 67.73% |
| 2002 Q2 | -330.35 Thousand USD | 2.07% |
| 2002 Q4 | -198.74 Thousand USD | -86.44% |
| 2001 Q1 | -1.02 Million USD | 5.98% |
| 2001 FY | - USD | -57.49% |
| 2001 Q4 | -742.9 Thousand USD | 29.68% |
| 2001 Q3 | 7243.00 USD | 17.28% |
| 2001 Q2 | -22.15 Thousand USD | -32.41% |
| 2000 Q1 | -82.65 Thousand USD | 84.69% |
| 2000 Q4 | -1.02 Million USD | -55.26% |
| 2000 Q3 | -660.69 Thousand USD | 20.84% |
| 2000 Q2 | -834.65 Thousand USD | -909.86% |
| 2000 FY | - USD | -213.58% |
| 1999 Q1 | -250 Thousand USD | -225.78% |
| 1999 Q3 | -130 Thousand USD | -333.33% |
| 1999 Q4 | -540 Thousand USD | -315.38% |
| 1999 FY | - USD | 7.86% |
| 1999 Q2 | -30 Thousand USD | 88.0% |
| 1998 Q4 | 198.76 Thousand USD | 298.77% |
| 1998 Q1 | -500 Thousand USD | -404.9% |
| 1998 Q2 | -200 Thousand USD | 60.0% |
| 1998 Q3 | -100 Thousand USD | 50.0% |
| 1998 FY | - USD | 27.09% |
| 1997 FY | - USD | 0.0% |
| 1997 Q1 | -200 Thousand USD | 0.0% |
| 1997 Q3 | -200 Thousand USD | 71.43% |
| 1997 Q4 | 163.98 Thousand USD | 181.99% |
| 1997 Q2 | -700 Thousand USD | -250.0% |
| 1996 Q3 | -200 Thousand USD | 83.55% |
| 1996 Q1 | -200 Thousand USD | 60.0% |
| 1996 Q2 | -1.21 Million USD | -508.08% |
| 1996 FY | - USD | 100.0% |
| 1995 Q3 | -300 Thousand USD | -195.46% |
| 1995 FY | - USD | 42.26% |
| 1995 Q1 | -500 Thousand USD | -110.87% |
| 1995 Q4 | -500 Thousand USD | -66.67% |
| 1995 Q2 | 314.27 Thousand USD | 162.85% |
| 1994 Q2 | -300 Thousand USD | 70.0% |
| 1994 Q3 | -400 Thousand USD | -33.33% |
| 1994 Q1 | -1 Million USD | -150.0% |
| 1994 FY | - USD | 65.22% |
| 1994 Q4 | 4.6 Million USD | 1250.0% |
| 1993 FY | - USD | -38.0% |
| 1993 Q4 | -400 Thousand USD | 20.0% |
| 1993 Q3 | -500 Thousand USD | 66.67% |
| 1993 Q2 | -1.5 Million USD | -7.14% |
| 1993 Q1 | -1.4 Million USD | 30.0% |
| 1992 Q2 | -5.1 Million USD | -5200.0% |
| 1992 FY | - USD | -85.19% |
| 1992 Q4 | -2 Million USD | -5.26% |
| 1992 Q3 | -1.9 Million USD | 62.75% |
| 1992 Q1 | 100 Thousand USD | 108.33% |
| 1991 Q4 | -1.1 Million USD | -1300.0% |
| 1991 FY | - USD | -58.82% |
| 1991 Q2 | -2.8 Million USD | -2900.0% |
| 1991 Q1 | 100 Thousand USD | 0.0% |
| 1991 Q3 | 100 Thousand USD | 103.57% |
| 1990 Q3 | -900 Thousand USD | 50.0% |
| 1990 Q4 | 100 Thousand USD | 111.11% |
| 1990 Q1 | 100 Thousand USD | 0.0% |
| 1990 FY | - USD | -466.67% |
| 1990 Q2 | -1.8 Million USD | -1900.0% |
| 1989 Q1 | 100 Thousand USD | 0.0% |
| 1989 FY | - USD | 0.0% |
| 1989 Q4 | 100 Thousand USD | 0.0% |
| 1989 Q3 | 100 Thousand USD | 125.0% |
| 1989 Q2 | -400 Thousand USD | -500.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Akoya Biosciences, Inc. | -45.63 Million USD | 0.863% |
| AngioDynamics, Inc. | -14.29 Million USD | -216.527% |
| AtriCure, Inc. | -8.1 Million USD | -457.874% |
| Avinger, Inc. | -16.34 Million USD | -176.753% |
| Azenta, Inc. | 55.15 Million USD | 182.026% |
| The Cooper Companies, Inc. | 882.8 Million USD | 105.124% |
| Daxor Corporation | 329.74 Thousand USD | 13819.294% |
| Ekso Bionics Holdings, Inc. | -13.19 Million USD | -242.764% |
| Femasys Inc. | -13.16 Million USD | -243.508% |
| GlucoTrack, Inc. | -7.09 Million USD | -537.964% |
| Harvard Bioscience, Inc. | 9.49 Million USD | 576.541% |
| Hologic, Inc. | 1.29 Billion USD | 103.49% |
| ICU Medical, Inc. | 307.69 Million USD | 114.702% |
| Intuitive Surgical, Inc. | 2.39 Billion USD | 101.89% |
| KORU Medical Systems, Inc. | -9.39 Million USD | -381.276% |
| LeMaitre Vascular, Inc. | 48.99 Million USD | 192.341% |
| Innovative Eyewear, Inc. | -6.57 Million USD | -588.016% |
| Innovative Eyewear, Inc. | -6.57 Million USD | -588.016% |
| Masimo Corporation | 236.7 Million USD | 119.112% |
| Microbot Medical Inc. | -10.63 Million USD | -325.409% |
| Meihua International Medical Technologies Co., Ltd. | 15.77 Million USD | 386.851% |
| Merit Medical Systems, Inc. | 231.44 Million USD | 119.546% |
| Nephros, Inc. | -1.37 Million USD | -3180.493% |
| NovoCure Limited | -175.86 Million USD | 74.277% |
| NEXGEL, Inc. | -2.73 Million USD | -1557.07% |
| NEXGEL, Inc. | -2.73 Million USD | -1557.07% |
| Singular Genomics Systems, Inc. | -86.49 Million USD | 47.699% |
| OraSure Technologies, Inc. | 76.15 Million USD | 159.4% |
| Pro-Dex, Inc. | 8.33 Million USD | 642.878% |
| Pulse Biosciences, Inc. | -42.36 Million USD | -6.777% |
| Predictive Oncology Inc. | -13.18 Million USD | -243.18% |
| Precision Optics Corporation, Inc. | -2.51 Million USD | -1700.911% |
| QuidelOrtho Corporation | 545.6 Million USD | 108.291% |
| Repligen Corporation | 124.29 Million USD | 136.397% |
| Sanara MedTech Inc. | -289.09 Thousand USD | -15548.035% |
| STAAR Surgical Company | 33.22 Million USD | 236.173% |
| Sharps Technology, Inc. | -8.98 Million USD | -403.742% |
| Utah Medical Products, Inc. | 24.8 Million USD | 282.375% |
| DENTSPLY SIRONA Inc. | 232 Million USD | 119.499% |
| Jin Medical International Ltd. | 3.44 Million USD | 1413.956% |